Position in OGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,711,036
+$4,123,543 QoQ
Shares Held
421,790
+59.2% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#73
of 626 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $2,173,508,170 across 16 Drug Manufacturers - General names. OGN ranks #15 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
547,546 | $656,743,153 | |
| 2 | JNJ |
Johnson & Johnson
|
1,756,229 | $446,029,479 | |
| 3 | ABBV |
AbbVie Inc.
|
1,138,736 | $286,551,527 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,523,212 | $195,732,742 | |
| 5 | AMGN |
Amgen Inc
|
425,632 | $154,129,859 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
722,993 | $91,342,935 | |
| 7 | PFE |
Pfizer Inc
|
2,712,410 | $65,314,832 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,121,564 | $64,624,517 |
All Filings in OGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,711,036 | 421,790 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,587,493 | 265,024 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,606,223 | 363,490 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,544,231 | 144,591 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $768,214 | 79,361 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,016,212 | 68,248 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $330,940 | 22,181 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $351,705 | 18,385 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $230,453 | 11,133 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||